Aadi Bioscience Inc (NAS:AADI)
$ 1.99 0.03 (1.53%) Market Cap: 48.98 Mil Enterprise Value: -29.27 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 42/100

Q2 2022 Aadi Bioscience Inc Earnings Call Transcript

Aug 10, 2022 / 12:30PM GMT
Release Date Price: $13.88 (-1.49%)
Operator

Good day and thank you for standing by. Welcome to the Aadi Bioscience, Inc., Second Quarter 2022 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to Marcy Graham, Senior Vice President of Investor Relations and Corporate Communications at Aadi Bioscience. Ms. Graham, please go ahead.

Marcy Graham
Aadi Bioscience, Inc. - SVP of IR & Corporate Communications

Thank you. Good morning and welcome to the Aadi Bioscience conference call to review results of and provide an update on second quarter 2022. Joining me on the call today is our President and CEO Neil Desai, who will provide an overview of the quarter; followed by Chief Operating Officer Brendan Delaney, who will give us an update on early commercial progress. Next will be our Chief Medical Officer, Dr. Loretta Itri, who will give us a brief update on our clinical progress; followed by our CFO, Scott Giacobello with a review of our financial performance during the period. We will close with some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot